Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology (vol 24, pg 1890, 2022)
Por:
Trigo, J, Garcia-Cosio, M, Garcia-Castano, A, Goma, M, Mesia-Nin, R, Ruiz-Bravo, E, Soria-Rivas, A, Castillo, P, Brana-Garcia, I and Alberola-Ferranti, M
Ahead of Print:
1 sep 2022
Resumen:
Filiaciones:
Trigo, J:
HC Marbella Int Hosp, Spanish Soc Med Oncol SEOM, Marbella, Spain
Garcia-Cosio, M:
Ramon y Cajal Univ Hosp, Spanish Soc Pathol Anat SEAP, Madrid, Spain
Garcia-Castano, A:
Marques de Valdecilla Univ Hosp, Spanish Soc Med Oncol SEOM, Santander, Spain
Goma, M:
Bellvitge Univ Hosp, Spanish Soc Pathol Anat SEAP, Lhospitalet De Llobregat, Spain
:
Germans Trias & Pujol Res Inst, Catalan Inst Oncol ICO, Badalona Appl Res Grp Oncol, Spanish Soc Med Oncol SEOM, Badalona, Spain
Ruiz-Bravo, E:
La Paz Univ Hosp, Spanish Soc Pathol Anat SEAP, Madrid, Spain
Soria-Rivas, A:
Ramon y Cajal Univ Hosp, Spanish Soc Med Oncol SEOM, Madrid, Spain
Castillo, P:
Clin Barcelona Hosp, Spanish Soc Pathol Anat SEAP, Barcelona, Spain
Brana-Garcia, I:
Vall dHebron Univ Hosp, Spanish Soc Med Oncol SEOM, Barcelona, Spain
Alberola-Ferranti, M:
Vall dHebron Univ Hosp, Spanish Soc Pathol Anat SEAP, Barcelona, Spain
hybrid
|